Holmium-166 Transarterial Radioembolization for the Treatment of Intrahepatic Cholangiocarcinoma: A Case Series
Background: Transarterial radioembolization (TARE) is used to treat primary and secondary malignancies in the liver that are not amenable to curative resection. Accumulating evidence demonstrates the efficacy and safety of TARE with yttrium-90 (<sup>90</sup>Y), which is the most widely u...
Main Authors: | Sim Vermeulen, Katrien De Keukeleire, Nicole Dorny, Isabelle Colle, Bert Van Den Bossche, Victor Nuttens, Dirk Ooms, Pieter De Bondt, Olivier De Winter |
---|---|
Format: | Article |
Language: | English |
Published: |
MDPI AG
2023-09-01
|
Series: | Cancers |
Subjects: | |
Online Access: | https://www.mdpi.com/2072-6694/15/19/4791 |
Similar Items
-
Transarterial Radioembolization Planning and Treatment with Microspheres Containing Holmium-166: Determination of Renal and Intestinal Radionuclide Elimination, Effective Half-Life, and Regulatory Aspects
by: Christian Kühnel, et al.
Published: (2022-12-01) -
Clinical Results of Transarterial Radioembolization (TARE) with Holmium-166 Microspheres in the Multidisciplinary Oncologic Treatment of Patients with Primary and Secondary Liver Cancer
by: Robert Drescher, et al.
Published: (2023-06-01) -
Radioembolization for hepatocellular carcinoma: what clinicians need to know
by: Jin Woo Choi, et al.
Published: (2022-03-01) -
Automatic healthy liver segmentation for holmium-166 radioembolization dosimetry
by: Martina Stella, et al.
Published: (2023-07-01) -
Transarterial chemoembolization as an alternative to radioembolization is associated with earlier tumor recurrence than in radioembolization-eligible patients
by: Sung Won Chung, et al.
Published: (2023-02-01)